The test, called HPV-DeepSeek, detects microscopic fragments of HPV DNA that have broken off from a tumor and entered the ...

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck ...

The FDA has granted fast track designation to the antibody-drug conjugate (ADC) CRB-701 for the treatment of recurrent or ...

While some patients may view head and neck cancer screenings as an unnecessary optional screening, these exams can be ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed ...

First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months) and Keytruda® + chemotherapy (12.3 months) in patients ...

Nanobiotix S.A. stock surges on promising cancer trial results and major partnership. Click for more on NBTX stock and why ...

Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted ...

Completing treatment for head and neck cancer is a milestone, but recovery is an ongoing journey. With follow-ups, ...

Recent treatment innovations for lung cancer and melanoma have improved survival overall but also increased disparities in survival according to income, researchers found.

Actor Nafisa Ali Sodhi starts chemo for ovarian cancer relapse. Oncologist explains why pap smears can’t detect the disease ...

The latest announcement is out from PDS Biotechnology ( (PDSB) ).